GlatiramerImmuneSafety Rating 8/10
Primary research areaRelapsing forms of multiple sclerosis
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range20 mg daily or 40 mg three times weekly SC
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Copaxone)
NCAA D1Permitted
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Glatiramer
Mechanism of action
Random amino acid copolymer modifying immune response to myelin antigens via T-cell modulation
Safety profile
Injection site reactions, post-injection flushing, chest pain, lipoatrophy · Decades of MS use; injection site reactions; post-injection reaction syndrome; excellent long-term safety
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Glatiramer below your target.
Related pages